We are live on ! Find out more
NTC

North Tide Capital Portfolio holdings

AUM $469M
1-Year Est. Return 6.57%
This Fund
S&P 500
This Quarter Est. Return
+12.54%
1 Year Est. Return
+6.57%
3 Year Est. Return
+14.81%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.14B
AUM Growth
+$188M
Cap. Flow
+$105M
Cap. Flow %
9.22%
Top 10 Hldgs %
63.65%
Holding
34
New
7
Increased
11
Reduced
7
Closed
6

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$54.7M
2
LH icon
Labcorp
LH
+$49.6M
3
AGN
Allergan Inc
AGN
+$43M
4
ESRX
Express Scripts Holding Company
ESRX
+$32.7M
5
SEM
Select Medical
SEM
+$27.2M

Top Sells

Rank Stock Value
1
CYH icon
Community Health Systems
CYH
+$41.5M
2
WCRX
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
+$41.3M
3
VOLC
VOLCANO CORPORATION COM STK
VOLC
+$19.2M
4
HNT
HEALTH NET INC
HNT
+$19M
5
ELV icon
Elevance Health
ELV
+$13.3M

Sector Composition

Rank Sector Weight
1 Healthcare 78.71%
2 Consumer Discretionary 2.15%
3 Financials 1.02%
4 Industrials 0.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEVA icon
1
Teva Pharmaceuticals
TEVA
$35.9B
$110M 9.66%
2,750,000
+425,000
+18% +$16.7M
ISRG icon
2
PUT
Intuitive Surgical
ISRG
$121B
$108M 9.42%
2,520,000
-675,000
-21% -$28.4M
ELV icon
3
Elevance Health
ELV
$81.9B
$83.2M 7.29%
900,000
-150,000
-14% -$13.3M
SEM
4
DELISTED
Select Medical
SEM
$81.3M 7.12%
12,992,000
+5,568,000
+75% +$27.2M
AGN
5
DELISTED
Allergan plc
AGN
$75.6M 6.62%
450,000
+350,000
+350% +$54.7M
TVTY
6
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$59.1M 5.18%
3,850,000
+1,050,000
+38% +$14.9M
NUVA
7
DELISTED
NuVasive, Inc.
NUVA
$55M 4.82%
1,700,000
-50,000
-3% -$1.5M
DGX icon
8
Quest Diagnostics
DGX
$25.1B
$53.5M 4.69%
1,000,000
+300,000
+43% +$17.8M
WCG
9
DELISTED
Wellcare Health Plans, Inc.
WCG
$51.1M 4.47%
725,000
-25,000
-3% -$1.75M
AGN
10
DELISTED
Allergan Inc
AGN
$50M 4.38%
+450,000
New +$43M
VTRS icon
11
Viatris
VTRS
$20.1B
$49.9M 4.37%
1,150,000
-250,000
-18% -$10.3M
BSX icon
12
Boston Scientific
BSX
$65.8B
$48.1M 4.21%
4,000,000
-600,000
-13% -$7.09M
AMED
13
DELISTED
Amedisys
AMED
$46.8M 4.1%
3,200,000
+450,000
+16% +$7.25M
LH icon
14
Labcorp
LH
$24.3B
$45.7M 4%
+582,000
New +$49.6M
MGLN
15
DELISTED
Magellan Health Services, Inc.
MGLN
$35.9M 3.15%
600,000
+160,700
+37% +$9.59M
ESRX
16
DELISTED
Express Scripts Holding Company
ESRX
$35.1M 3.08%
+500,000
New +$32.7M
ELOS
17
DELISTED
Syneron Medical Ltd
ELOS
$28.9M 2.53%
2,350,000
+200,000
+9% +$2.08M
AFAM
18
DELISTED
Almost Family Inc
AFAM
$24.5M 2.15%
757,399
+64,821
+9% +$1.59M
KND
19
DELISTED
Kindred Healthcare
KND
$19.7M 1.73%
1,000,000
+300,000
+43% +$4.83M
OFIX icon
20
Orthofix Medical
OFIX
$455M
$15.4M 1.35%
+675,000
New +$14.1M
CNMD icon
21
CONMED
CNMD
$1.29B
$14.9M 1.3%
350,000
+110,413
+46% +$4.2M
EHTH icon
22
eHealth
EHTH
$42.5M
$11.6M 1.02%
250,000
-250,000
-50% -$10.4M
MYGN icon
23
Myriad Genetics
MYGN
$530M
$10.5M 0.92%
+500,000
New +$12.6M
SVU
24
DELISTED
SUPERVALU Inc.
SVU
$9.84M 0.86%
192,857
– –
CCRN
25
DELISTED
Cross Country Healthcare
CCRN
$6.74M 0.59%
675,000
– –
1
2

Similar funds

SD
Sumway Development Shanghai, China $427M AUM 43.82% 1-Year Est. Return
DG
Davidson & Garrard Lynchburg, Virginia $425M AUM 14.62% 1-Year Est. Return
NBC
Neuberger Berman Canada Toronto, Ontario, Canada $542M AUM 14.17% 1-Year Est. Return
JWM
Jacobus Wealth Management Milwaukee, Wisconsin $382M AUM 16.31% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return
MCL
MIK Capital LLC New York $344M AUM 26.72% 1-Year Est. Return
GIIO
Gen IV Investment Opportunities New York $269M AUM 21.06% 1-Year Est. Return
FC
FIC Capital New York $262M AUM 34.37% 1-Year Est. Return

North Tide Capital's Q4 2013 Portfolio in Review

As of Q4 2013, North Tide Capital held 34 positions worth $1.14B, up 20% from $953M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

North Tide Capital deployed $105M of net new capital in Q4 2013, opening 7 new positions and adding to 11 existing holdings. Its largest new stake was Labcorp: 582,000 shares worth $45.7M.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, up from 65% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Elevance Health, an estimated $13.3M trimmed.

  • North Tide Capital's largest Q4 2013 buy was Labcorp: 582,000 shares worth $45.7M.
  • North Tide Capital added most to Allergan plc in Q4 2013, an estimated $54.7M increase.
  • North Tide Capital's biggest Q4 2013 reduction was Elevance Health, cutting an estimated $13.3M.
  • North Tide Capital fully exited Community Health Systems in Q4 2013, selling an estimated $41.5M.
  • North Tide Capital's ten largest holdings make up 64% of its $1.14B portfolio in Q4 2013.
  • North Tide Capital opened 7 new positions and closed 6 in Q4 2013.
  • North Tide Capital's portfolio value rose 20% quarter-over-quarter to $1.14B.

Based on North Tide Capital's 13F filing for Q4 2013, filed 14 Feb 2014.